127 related articles for article (PubMed ID: 2121016)
1. Recombinant tissue-type plasminogen activator followed by heparin compared with heparin alone for refractory unstable angina pectoris.
Ardissino D; Barberis P; De Servi S; Mussini A; Rolla A; Visani L; Specchia G
Am J Cardiol; 1990 Oct; 66(12):910-4. PubMed ID: 2121016
[TBL] [Abstract][Full Text] [Related]
2. A randomized, blinded, placebo-controlled trial of recombinant human tissue-type plasminogen activator in patients with unstable angina pectoris.
Gold HK; Johns JA; Leinbach RC; Yasuda T; Grossbard E; Zusman R; Collen D
Circulation; 1987 Jun; 75(6):1192-9. PubMed ID: 3105913
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of prolonged low dose recombinant tissue-type plasminogen activator for refractory unstable angina.
Romeo F; Rosano GM; Martuscelli E; Comito M; Cardona N; Colistra C; Milano B; Bianco C; Rosano V
J Am Coll Cardiol; 1995 May; 25(6):1295-9. PubMed ID: 7722124
[TBL] [Abstract][Full Text] [Related]
4. Thrombolysis in unstable angina. Randomized double-blind trial of t-PA and placebo.
Freeman MR; Langer A; Wilson RF; Morgan CD; Armstrong PW
Circulation; 1992 Jan; 85(1):150-7. PubMed ID: 1728444
[TBL] [Abstract][Full Text] [Related]
5. Intravenous recombinant tissue-type plasminogen activator in patients with unstable angina pectoris. Results of a placebo-controlled, randomized trial.
Williams DO; Topol EJ; Califf RM; Roberts R; Mancini GB; Joelson JM; Ellis SG; Kleiman NS
Circulation; 1990 Aug; 82(2):376-83. PubMed ID: 2115407
[TBL] [Abstract][Full Text] [Related]
6. Randomized, double-blind, placebo-controlled trial of tissue plasminogen activator in unstable angina.
Nicklas JM; Topol EJ; Kander N; O'Neill WW; Walton JA; Ellis SG; Gorman L; Pitt B
J Am Coll Cardiol; 1989 Feb; 13(2):434-41. PubMed ID: 2492325
[TBL] [Abstract][Full Text] [Related]
7. [Intravenous thrombolysis by recombinant plasminogen activator (rt-PA) in unstable angina. A randomized multicenter study versus placebo].
Charbonnier B; Bernadet P; Schiele F; Thery C; Baudouy M; Bauters C
Arch Mal Coeur Vaiss; 1992 Oct; 85(10):1471-7. PubMed ID: 1297297
[TBL] [Abstract][Full Text] [Related]
8. Coronary revascularization after intravenous tissue plasminogen activator for unstable angina pectoris: results of a randomized, double-blind, placebo-controlled trial.
Topol EJ; Nicklas JM; Kander NH; Walton JA; Ellis SG; Gorman L; Pitt B
Am J Cardiol; 1988 Sep; 62(7):368-71. PubMed ID: 2970776
[TBL] [Abstract][Full Text] [Related]
9. Tissue plasminogen activator in refractory unstable angina. A randomized double-blind placebo-controlled trial in patients with refractory unstable angina and subsequent angioplasty.
van den Brand M; van Zijl A; Geuskens R; de Feyter PJ; Serruys PW; Simoons ML
Eur Heart J; 1991 Nov; 12(11):1208-14. PubMed ID: 1782951
[TBL] [Abstract][Full Text] [Related]
10. Failure of adjuvant heparin to reduce myocardial ischemia in the early treatment of patients with unstable angina.
Wallis DE; Boden WE; Califf R; Crawford MH; Hakki AH; Iskandrian AS; Labovitz A; O'Connor C; Sutton R; Scanlon PJ
Am Heart J; 1991 Oct; 122(4 Pt 1):949-54. PubMed ID: 1681722
[TBL] [Abstract][Full Text] [Related]
11. Heparin is more effective than inogatran, a low-molecular weight thrombin inhibitor in suppressing ischemia and recurrent angina in unstable coronary disease. Thrombin Inhibition in Myocardial Ischemia (TRIM) Study Group.
Andersen K; Dellborg M
Am J Cardiol; 1998 Apr; 81(8):939-44. PubMed ID: 9576150
[TBL] [Abstract][Full Text] [Related]
12. Thrombolytic therapy in refractory unstable angina: the role of Holter monitoring.
Brunelli C; Spallarossa P; Ghigliotti G; Lantieri P; Iannetti M; Caponnetto S
Clin Cardiol; 1991 Apr; 14(4):297-304. PubMed ID: 1674454
[TBL] [Abstract][Full Text] [Related]
13. Urokinase plus heparin versus aspirin in unstable angina and non-Q-wave myocardial infarction.
Schreiber TL; Macina G; McNulty A; Bunnell P; Kikel M; Miller DH; Devereux RB; Tenney R; Cowley M; Zola B
Am J Cardiol; 1989 Oct; 64(14):840-4. PubMed ID: 2801550
[TBL] [Abstract][Full Text] [Related]
14. Anti-ischemic and anti-anginal effects of thoracic epidural anesthesia versus those of conventional medical therapy in the treatment of severe refractory unstable angina pectoris.
Olausson K; Magnusdottir H; Lurje L; Wennerblom B; Emanuelsson H; Ricksten SE
Circulation; 1997 Oct; 96(7):2178-82. PubMed ID: 9337187
[TBL] [Abstract][Full Text] [Related]
15. Variables predictive of successful medical therapy in patients with unstable angina: selection by multivariate analysis from clinical, electrocardiographic, and angiographic evaluations.
Ouyang P; Brinker JA; Mellits ED; Weisfeldt ML; Gerstenblith G
Circulation; 1984 Sep; 70(3):367-76. PubMed ID: 6378422
[TBL] [Abstract][Full Text] [Related]
16. Hemorrhagic events during therapy with recombinant tissue plasminogen activator, heparin, and aspirin for unstable angina (Thrombolysis in Myocardial Ischemia, phase IIIB trial).
Bovill EG; Tracy RP; Knatterud GL; Stone PH; Nasmith J; Gore JM; Thompson BW; Tofler GH; Kleiman NS; Cannon C; Braunwald E
Am J Cardiol; 1997 Feb; 79(4):391-6. PubMed ID: 9052337
[TBL] [Abstract][Full Text] [Related]
17. Effect of heparin, aspirin, or alteplase in reduction of myocardial ischaemia in refractory unstable angina.
Neri Serneri GG; Gensini GF; Poggesi L; Trotta F; Modesti PA; Boddi M; Ieri A; Margheri M; Casolo GC; Bini M
Lancet; 1990 Mar; 335(8690):615-8. PubMed ID: 1969013
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the effect of heparin and aspirin versus aspirin alone on transient myocardial ischemia and in-hospital prognosis in patients with unstable angina.
Holdright D; Patel D; Cunningham D; Thomas R; Hubbard W; Hendry G; Sutton G; Fox K
J Am Coll Cardiol; 1994 Jul; 24(1):39-45. PubMed ID: 8006281
[TBL] [Abstract][Full Text] [Related]
19. Low molecular weight heparin versus regular heparin or aspirin in the treatment of unstable angina and silent ischemia.
Gurfinkel EP; Manos EJ; Mejaíl RI; Cerdá MA; Duronto EA; García CN; Daroca AM; Mautner B
J Am Coll Cardiol; 1995 Aug; 26(2):313-8. PubMed ID: 7608429
[TBL] [Abstract][Full Text] [Related]
20. Effect of maximal medical therapy on refractoriness of unstable angina pectoris.
Grambow DW; Topol EJ
Am J Cardiol; 1992 Sep; 70(6):577-81. PubMed ID: 1354937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
